Syneron Medical (NASDAQ: ELOS) and ICU Medical (NASDAQ:ICUI) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.
Risk and Volatility
Syneron Medical has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500.
This table compares Syneron Medical and ICU Medical’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|ICU Medical||$1.29 billion||3.98||$68.64 million||$3.33||76.68|
ICU Medical has higher revenue and earnings than Syneron Medical.
This is a breakdown of recent recommendations and price targets for Syneron Medical and ICU Medical, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Syneron Medical currently has a consensus price target of $11.00, suggesting a potential upside of 0.00%. Given Syneron Medical’s higher probable upside, equities research analysts clearly believe Syneron Medical is more favorable than ICU Medical.
Institutional & Insider Ownership
69.2% of Syneron Medical shares are held by institutional investors. Comparatively, 77.3% of ICU Medical shares are held by institutional investors. 13.6% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
This table compares Syneron Medical and ICU Medical’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
ICU Medical beats Syneron Medical on 8 of the 10 factors compared between the two stocks.
About Syneron Medical
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company’s products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.
About ICU Medical
ICU Medical, Inc. is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. The primary critical care products it manufactures are Hemodynamic Monitoring Systems, SafeSet Closed Blood Sampling and Conservation System, Transpac Consumable Blood Pressure Transducers and Other Critical Care Products. The primary oncology products it manufactures are ChemoLock Needlefree CSTD, ChemoClave Needlefree CSTD and Diana Hazardous Drug Compounding System. As of December 31, 2016, its products were used in acute care hospitals and ambulatory clinics in more than 65 countries throughout the world.
Receive News & Ratings for Syneron Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical and related companies with MarketBeat.com's FREE daily email newsletter.